BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 11704332)

  • 21. A feasibility study of automated inverse treatment planning for cancer of the prostate.
    Reinstein LE; Wang XH; Burman CM; Chen Z; Mohan R; Kutcher G; Leibel SA; Fuks Z
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):207-14. PubMed ID: 9422578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
    Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter.
    Schwarz M; Lebesque JV; Mijnheer BJ; Damen EM
    Radiother Oncol; 2004 Nov; 73(2):209-18. PubMed ID: 15542168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
    Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
    Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectum contouring variability in patients treated for prostate cancer: impact on rectum dose-volume histograms and normal tissue complication probability.
    Fiorino C; Vavassori V; Sanguineti G; Bianchi C; Cattaneo GM; Piazzolla A; Cozzarini C
    Radiother Oncol; 2002 Jun; 63(3):249-55. PubMed ID: 12142088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
    Cozzarini C; Fiorino C; Ceresoli GL; Cattaneo GM; Bolognesi A; Calandrino R; Villa E
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):688-94. PubMed ID: 12573756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dynamic compensation strategy to correct patient-positioning errors in conformal prostate radiotherapy.
    Lauve AD; Siebers JV; Crimaldi AJ; Hagan MP; Kealla PJ
    Med Phys; 2006 Jun; 33(6):1879-87. PubMed ID: 16872095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
    Tucker SL; Dong L; Cheung R; Johnson J; Mohan R; Huang EH; Liu HH; Thames HD; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1589-601. PubMed ID: 15590191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.
    Gordon JJ; Sayah N; Weiss E; Siebers JV
    Med Phys; 2010 Feb; 37(2):550-63. PubMed ID: 20229863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U; Bogner J; Georg D; Auberger T; Pötter R
    Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer.
    Marzi S; Arcangeli G; Saracino B; Petrongari MG; Bruzzaniti V; Iaccarino G; Landoni V; Soriani A; Benassi M
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):41-9. PubMed ID: 17276615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
    Bridges D; Kawamura H; Kanai T
    PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
    Mavroidis P; Ferreira BC; Lopes Mdo C
    Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy.
    Buffa FM; Davidson SE; Hunter RD; Nahum AE; West CM
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1113-22. PubMed ID: 11483320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH).
    Cheng CW; Das IJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1143-50. PubMed ID: 10192366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability.
    Stroom JC; de Boer HC; Huizenga H; Visser AG
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):905-19. PubMed ID: 10098447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiobiological parameters in a tumour control probability model for prostate cancer LDR brachytherapy.
    Her EJ; Reynolds HM; Mears C; Williams S; Moorehouse C; Millar JL; Ebert MA; Haworth A
    Phys Med Biol; 2018 Jun; 63(13):135011. PubMed ID: 29799812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.